MicroRNA-1179 inhibits glioblastoma cell proliferation and cell cycle progression via directly targeting E2F

Xiupeng Xu1, Ning Cai1, Tongle Zhi1

  • 1Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical UniversityNanjing 210000, Jiangsu, China.

Insights

MicroRNA-1179 (miR-1179) is downregulated in glioblastoma multiforme (GBM). Restoring miR-1179 suppresses GBM cell growth and tumor progression by targeting E2F transcription factor 5 (E2F5).

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with limited therapeutic options.
  • MicroRNAs (miRNAs) play critical roles in GBM pathogenesis, but the function of miR-1179 remains largely unexplored.
  • Identifying novel therapeutic targets is crucial for improving GBM treatment outcomes.

Purpose of the Study:

  • To investigate the role of miR-1179 in glioblastoma multiforme (GBM) progression.
  • To elucidate the molecular mechanisms underlying miR-1179's function in GBM.
  • To assess the therapeutic potential of miR-1179 in GBM.

Main Methods:

  • Quantitative real-time PCR to measure miR-1179 expression in glioma tissues and cell lines.
  • In vitro functional assays (cell proliferation, cell cycle analysis) following miR-1179 introduction.
  • In vivo studies using a subcutaneous GBM xenograft model to evaluate miR-1179's effect on tumor growth.
  • Luciferase reporter assays and Western blotting to identify and validate E2F transcription factor 5 (E2F5) as a direct target of miR-1179.
  • Rescue experiments involving E2F5 reintroduction into GBM cells.

Main Results:

  • miR-1179 was significantly downregulated in glioma tissues and cell lines compared to normal controls.
  • Overexpression of miR-1179 suppressed GBM cell proliferation, induced cell cycle arrest, and inhibited tumor growth in vivo.
  • E2F transcription factor 5 (E2F5) was identified as a direct target of miR-1179, and its knockdown mimicked miR-1179's effects.
  • Reintroduction of E2F5 reversed the tumor-suppressive effects of miR-1179.
  • A negative correlation was observed between miR-1179 expression and E2F5 mRNA levels in high-grade gliomas.

Conclusions:

  • miR-1179 functions as a tumor suppressor in glioblastoma multiforme (GBM).
  • miR-1179 inhibits GBM progression by directly targeting E2F transcription factor 5 (E2F5), thereby regulating cell cycle progression.
  • miR-1179 represents a potential therapeutic candidate for GBM treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K